These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 315322)

  • 21. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxepin as a blocker of central serotonin receptors.
    Maj J; Gancarczyk L; Górszczyk L; Rawłów A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Dec; 10(6):318-24. PubMed ID: 309138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
    Spinedi E; Gaillard RC
    J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and behavior: a brief summary.
    Aprison MH; Hingtgen JN
    Fed Proc; 1972; 31(1):121-9. PubMed ID: 4333248
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of fluoxetine on a specific serotonergic syndrome in rats.
    Keshavan HJ; Gurbani NK; Dandiya PC
    Indian J Med Res; 1981 Apr; 73():653-7. PubMed ID: 6973540
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment.
    Häidkind R; Eller M; Kask A; Harro M; Rinken A; Oreland L; Harro J
    Neurochem Int; 2004 Oct; 45(5):721-32. PubMed ID: 15234115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonergic stimulation of pituitary-adrenal activity in the mouse.
    Meyer JS; Buckholtz NS; Boggan WO
    Neuroendocrinology; 1978; 26(5):312-24. PubMed ID: 150549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT syndrome and the drug discrimination paradigm in rats: application in behavioral studies on the central 5-HT system.
    Ortmann R
    Pharmacopsychiatry; 1985 Mar; 18(2):198-201. PubMed ID: 3875109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin II on some behavioral and neurochemical measures of the central serotonine system.
    Braszko JJ; Majewski K; Maciejewski A; Wisniewski K
    Biomed Biochim Acta; 1985; 44(9):1359-68. PubMed ID: 3878708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonergic modulation of footshock induced aggression in paired rats.
    Datla KP; Mitra SK; Bhattacharya SK
    Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 34. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat.
    Dyck LE; Kazakoff CW; Dourish CT
    Eur J Pharmacol; 1982 Oct; 84(3-4):139-49. PubMed ID: 7173317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
    Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotoninergic manipulation of the behavioral effects of cocaine in rats.
    Pradhan SN; Battacharyya AK; Pradhan S
    Commun Psychopharmacol; 1978; 2(6):481-6. PubMed ID: 311720
    [No Abstract]   [Full Text] [Related]  

  • 39. Specificity of a rat behavioral model for serotonin receptor activation.
    Sloviter RS; Drust EG; Connor JD
    J Pharmacol Exp Ther; 1978 Aug; 206(2):339-47. PubMed ID: 682117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
    Kehr W
    Eur J Pharmacol; 1977 Feb; 41(3):261-73. PubMed ID: 837971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.